(Q43921031)

English

Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

0 references

1 reference

based on heuristic

inferred from title

acute lymphocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

6

object named as

Hagop M Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2

object named as

Susan O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Mary A Weiser

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Deborah A Thomas

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sherry A Pierce

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tony P Lam

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

94

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

285-291

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Delaying treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for hematological malignancies: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10241

21 January 2018

Identifiers

10.1002/CNCR.10241

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43921031&oldid=2104404649"